JP2021533142A5 - - Google Patents
Info
- Publication number
- JP2021533142A5 JP2021533142A5 JP2021505954A JP2021505954A JP2021533142A5 JP 2021533142 A5 JP2021533142 A5 JP 2021533142A5 JP 2021505954 A JP2021505954 A JP 2021505954A JP 2021505954 A JP2021505954 A JP 2021505954A JP 2021533142 A5 JP2021533142 A5 JP 2021533142A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antigen
- composition according
- antibody
- binding fragment
- Prior art date
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862717435P | 2018-08-10 | 2018-08-10 | |
| US62/717,435 | 2018-08-10 | ||
| US201862764816P | 2018-08-15 | 2018-08-15 | |
| US62/764,816 | 2018-08-15 | ||
| PCT/US2019/045970 WO2020033872A1 (en) | 2018-08-10 | 2019-08-09 | A pharmaceutical composition for safe and effective treatment of knee and/or hip pain |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021533142A JP2021533142A (ja) | 2021-12-02 |
| JP2021533142A5 true JP2021533142A5 (https=) | 2022-08-12 |
| JPWO2020033872A5 JPWO2020033872A5 (https=) | 2022-08-12 |
| JP7460598B2 JP7460598B2 (ja) | 2024-04-02 |
Family
ID=67811008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021505954A Active JP7460598B2 (ja) | 2018-08-10 | 2019-08-09 | 膝および／または股関節痛の安全で効果的な処置用の医薬組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11472870B2 (https=) |
| EP (1) | EP3833687A1 (https=) |
| JP (1) | JP7460598B2 (https=) |
| KR (1) | KR20210043624A (https=) |
| CN (1) | CN112839956A (https=) |
| AU (1) | AU2019318556A1 (https=) |
| CA (1) | CA3108697A1 (https=) |
| IL (1) | IL280550B2 (https=) |
| MX (1) | MX2021001549A (https=) |
| WO (1) | WO2020033872A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7532290B2 (ja) * | 2021-03-09 | 2024-08-13 | エヌ・ティ・ティ・コミュニケーションズ株式会社 | 患者追跡調査支援システム、患者追跡調査支援方法、支援制御装置、端末装置およびプログラム |
| EP4433500A1 (en) | 2021-11-19 | 2024-09-25 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for reducing centralized pain |
| US20240002491A1 (en) * | 2022-04-27 | 2024-01-04 | Regeneron Pharmaceuticals, Inc. | Methods for selecting patients for treatment with an ngf antagonist |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6927044B2 (en) | 1998-09-25 | 2005-08-09 | Regeneron Pharmaceuticals, Inc. | IL-1 receptor based cytokine traps |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| CN101014364B (zh) | 2002-12-24 | 2012-01-18 | 里纳特神经系统学公司 | 抗ngf抗体及其使用方法 |
| US7569364B2 (en) * | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
| ME00226B (me) * | 2004-07-15 | 2011-02-10 | Medarex Llc | Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| US8309088B2 (en) * | 2007-08-10 | 2012-11-13 | Regeneron Pharmaceuticals, Inc. | Method of treating osteoarthritis with an antibody to NGF |
| BRPI0815370B8 (pt) | 2007-08-10 | 2021-05-25 | Regeneron Pharma | anticorpos humanos de alta afinidade contra o fator de crescimento neural humano e seu uso, molécula de ácido nucleico, vetor de expressão, método para produção de um anticorpo anti-ngf humano e composiçao farmacêutica |
| PE20130203A1 (es) | 2010-03-17 | 2013-03-24 | Abbott Res Bv | Composiciones de anticuerpos anti-factor de crecimiento nervioso (ngf) |
| JOP20190250A1 (ar) | 2010-07-14 | 2017-06-16 | Regeneron Pharma | صيغ مستقرة تحتوي على الأجسام المضادة لمضاد عامل نمو الأعصاب |
| BR112013008366B1 (pt) | 2010-10-06 | 2022-02-08 | Regeneron Pharmaceuticals, Inc | Formulações farmacêuticas líquidas estáveis contendo anticorpos anti-receptor de interleucina-4 humana alfa, e recipiente contendo as referidas formulações |
| EP2859018B1 (en) * | 2012-06-06 | 2021-09-22 | Zoetis Services LLC | Caninized anti-ngf antibodies and methods thereof |
| US10736961B2 (en) | 2016-11-29 | 2020-08-11 | Regeneron Pharmaceuticals, Inc. | Method of averting opioid addiction |
-
2019
- 2019-08-09 KR KR1020217007170A patent/KR20210043624A/ko not_active Ceased
- 2019-08-09 AU AU2019318556A patent/AU2019318556A1/en active Pending
- 2019-08-09 EP EP19762255.8A patent/EP3833687A1/en active Pending
- 2019-08-09 WO PCT/US2019/045970 patent/WO2020033872A1/en not_active Ceased
- 2019-08-09 JP JP2021505954A patent/JP7460598B2/ja active Active
- 2019-08-09 MX MX2021001549A patent/MX2021001549A/es unknown
- 2019-08-09 US US16/536,706 patent/US11472870B2/en active Active
- 2019-08-09 IL IL280550A patent/IL280550B2/en unknown
- 2019-08-09 CN CN201980066402.2A patent/CN112839956A/zh active Pending
- 2019-08-09 CA CA3108697A patent/CA3108697A1/en active Pending
-
2021
- 2021-10-26 US US17/510,798 patent/US20220041708A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016136364A (ru) | Способы лечения или предупреждения астмы посредством введения антагониста il-4r | |
| JP2018512435A5 (https=) | ||
| JP2013542194A5 (https=) | ||
| RU2019134352A (ru) | Новые биспецифические антигенсвязывающие молекулы, обладающие способностью специфически связываться с cd40 и fap | |
| RU2016130056A (ru) | Способы лечения кожной инфекции путем введения антагониста il-4r | |
| RU2012156938A (ru) | Антитела против gdf8 человека | |
| RU2013155906A (ru) | Антитела анти-angptl3 и их применение | |
| RU2017108173A (ru) | Комбинированная терапия на основе антител, активирующих человеческий cd40, и антител к человеческому pd-l1 | |
| ME02239B (me) | Humana antitela visokog afiniteta prema humanom nervnom faktoru rasta | |
| TW202311284A (zh) | 抗金黃色葡萄球菌溶血素ａ毒素之人類抗體 | |
| RU2016122340A (ru) | Il-17a-связующий агент и способы его применения | |
| JP2019512472A5 (https=) | ||
| RU2017137496A (ru) | Средство для лечения множественной миеломы (ММ) | |
| JP2021533142A5 (https=) | ||
| JP2018529661A5 (https=) | ||
| AU2022200690B2 (en) | Method of treating tendinopathy using interleukin-17 (IL-17) antagonists | |
| JP2025072440A5 (https=) | ||
| CN106573059A (zh) | 接受过抗TNF‑α抗体疗法的银屑病患者的治疗方法 | |
| FI3880186T3 (fi) | PD-1-inhibiittoreiden intralesionaalinen antaminen ihosyövän hoitamiseksi | |
| JP2019535716A5 (https=) | ||
| JP2020535180A5 (https=) | ||
| JPWO2020033872A5 (https=) | ||
| EP4525914A1 (en) | Methods of selectively treating tendinopathy using interleukin-17 (il-17) antagonists | |
| RU2217166C2 (ru) | Гуманизированные антитела, которые распознают веротоксин ii, и продуцирующая их линия клеток | |
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 |